Findings
Houston, Texas
Volume 7, Issue 8
September 2009

Online resources help improve care for babies with jaundice

By Glenna Picton

Jochen Profit, M.D.
Jochen Profit, M.D.

Following the guidelines from the American Academy of Pediatrics for monitoring and diagnosing newborn jaundice can result in better treatment and fewer cases of kernicterus, a form of brain damage caused by excessive jaundice, according to a Baylor College of Medicine physician in a report in Pediatrics.

"Little is known about how well pediatricians follow the guidelines," said Dr. Jochen Profit, assistant professor of pediatrics – neonatology. "We hope this study will help educate pediatricians around the country about the importance of early follow-up care and support for newborns."

Online tool kit

In cooperation with clinicians from BCM, Texas Children's Hospital and others, the American Academy of Pediatrics has developed an online tool kit to help educate pediatricians on assessing the risk for jaundice, or hyperbilirubinemia, on supporting breastfeeding mothers and coordinating care between the hospital nursery and the pediatrician's office.

The academy guidelines include:

Hyperbilirubinemia occurs when there are high levels of a substance known as bilirubin in the blood. Bilirubin is formed when the body breaks down old red blood cells, causing yellowing of the skin (known as jaundice). In newborns bilirubin levels rise over the first few days and usually peak by three to seven days of age. Breastfed babies tend to have higher levels of bilirubin and for a longer time.

In some infants, bilirubin can build up to dangerous levels. If dangerous levels are detected, treatment can reduce the bilirubin level in the newborn's blood.

However, if missed or left untreated, high levels of bilirubin may cause kernicterus, a form of permanent brain damage.

Compliance issues

To assess compliance with the guidelines, Profit and colleagues reviewed the charts of 136 pediatricians to evaluate timing and content of the first newborn office visit.

They found that that only 37 percent of 698 newborns and only 41 percent of exclusively breastfed infants were seen within the recommended first six days.

Profit and his colleagues said the lack of follow-up might occur for several reasons.

Some doctors may be reassured by a predischarge bilirubin level that did not predict high risk for a later high bilirubin level. Others may not be willing to change their practice because they disagree with the guidelines as too stringent, burdensome to families or not cost-effective. Furthermore, insurance companies pay doctors very little for early follow-up visits.

"The problem of newborn follow-up care is not new. It is a very complicated process that requires a coordinated effort among patients, hospitals, pediatricians, and health insurers," said Profit, who is also assistant professor of medicine – health services research at BCM. "The American Academy of Pediatrics Safe and Healthy Beginnings Toolkit is an important step to promote a safer first week of life. Health insurers could support this goal by rewarding pediatricians or patients for appropriate newborn follow-up. "

A link to the study article in Pediatrics can be found at http://pediatrics.aappublications.org/.

Funding for the research came from the National Institutes of Health.